COVINNOVATIONS

Welcome to the Brand page for “COVINNOVATIONS”, which is offered here for Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, infectious disease, including covid-19; medical diagnostic reagents and assays for testing body fluids for microorganisms relating to infectious disease, including covid-19; medical diagnostic reagents and assays for testing of body fluids relating to infectious disease, including covid-19; therapeutic pharmaceutical for the treatment of infectious disease, including covid-19; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids relating to infectious disease, including covid-19; drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of infectious disease, including covid-19;medical diagnostic testing, monitoring and reporting services relating to infectious disease, including covid-19; medical services, the treatment of infectious disease through the use of diagnostic testing to determine key susceptibilities to identified viruses, including covid-19, and a course of therapeutics and pharmaceutical preparations in accordance with said susceptibilities; medical testing for diagnostic or treatment purposes relating to infectious disease, including covid-19; medical testing for diagnostic or treatment purposes in the field of infectious disease, including covid-19;diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing of infectious disease, including covid-19; medical diagnostic apparatus for testing dna and rna samples for infectious disease, including covid-19; medical diagnostic apparatus for testing for viruses, including covid-19; medical diagnostic apparatus for testing dna and rna samples for infectious disease, including covid-19; medical diagnostic apparatus for testing of nucleic acids for infectious disease, including covid-19;research and development and consultation related thereto in the field of infectious disease, including covid-19 testing; research and development in the field of infectious disease, including covid-19 testing; research and development in the pharmaceutical and biotechnology fields, relating to infectious disease, including covid-19; research and development of technology in the field of infectious disease, including covid-19 testing; research and development services in the field of antibodies relating to infectious disease, including covid-19; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines relating to infectious disease, including covid-19; scientific research and development relating to infectious disease, including covid-19; pharmaceutical research and development relating to infectious disease, including covid-19;.

Its status is currently believed to be active. Its class is unavailable. “COVINNOVATIONS” is believed to be currently owned by “Schaefflertanz Corporation”.

Owner:
SCHAEFFLERTANZ CORPORATION
Owner Details
Description:
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing body fluids for microorganisms relating to infectious disease, including COVID-19; Medical diagnostic reagents and assays for testing of body fluids relating to infectious disease, including COVID-19; Therapeutic pharmaceutical for the treatment of infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids relating to infectious disease, including COVID-19; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of infectious disease, including COVID-19;Medical diagnostic testing, monitoring and reporting services relating to infectious disease, including COVID-19; Medical services, the treatment of infectious disease through the use of diagnostic testing to determine key susceptibilities to identified viruses, including COVID-19, and a course of therapeutics and pharmaceutical preparations in accordance with said susceptibilities; Medical testing for diagnostic or treatment purposes relating to infectious disease, including COVID-19; Medical testing for diagnostic or treatment purposes in the field of infectious disease, including COVID-19;Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing of infectious disease, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing for viruses, including COVID-19; Medical diagnostic apparatus for testing DNA and RNA samples for infectious disease, including COVID-19; Medical diagnostic apparatus for testing of nucleic acids for infectious disease, including COVID-19;Research and development and consultation related thereto in the field of infectious disease, including COVID-19 testing; Research and development in the field of infectious disease, including COVID-19 testing; Research and development in the pharmaceutical and biotechnology fields, relating to infectious disease, including COVID-19; Research and development of technology in the field of infectious disease, including COVID-19 testing; Research and development services in the field of antibodies relating to infectious disease, including COVID-19; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines relating to infectious disease, including COVID-19; Scientific research and development relating to infectious disease, including COVID-19; Pharmaceutical research and development relating to infectious disease, including COVID-19;
Categories: DIAGNOSTIC KITS COMPRISED MEDICAL